Multi-site Left Ventricular (MSLV) Pacing With Quartet 1458Q Lead

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01044472

Acronym

MSLV

Enrollment

Registered

2010-01-08

Start date

2010-02-28

Completion date

2010-05-31

Last updated

2019-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multi-site Left Ventricular Pacing

Keywords

CRT-D

Brief summary

The purpose of this clinical investigation is to evaluate the safety and hemodynamic performance of the MSLV Pacing feature in a clinical setting.

Detailed description

To evaluate the hemodynamic impact of different pacing MSLV configurations.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients who have a recognised indication to receive a CRT-D device or an upgrade from a pacemaker or ICD to a CRT-D system. * Patients have signed an informed consent form indicating their willingness to participate to this study.

Exclusion criteria

* Patients who are unable to comply with the follow-up schedule based on their geographic location or for any reason. * Patients with second or third degree AV Block * Patients with intrinsic atrial rhythm \< 40 bpm * Patients with a previously implanted left ventricular pacing lead. * Patients who are pregnant. * Patients currently participating in a clinical investigation that includes an active treatment arm. * Patients under 18 years of age. * Patients with a life expectancy of less then 6 months.

Countries

Germany, United Kingdom

Outcome results